HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular mechanism of transforming growth factor (TGF)-beta1-induced glutathione depletion in alveolar epithelial cells. Involvement of AP-1/ARE and Fra-1.

Abstract
Glutathione (GSH) is a ubiquitous antioxidant in lung epithelial cells and lung lining fluid. Transforming growth factor beta1 (TGF-beta1) is a pleiotropic cytokine involved in cellular proliferation and differentiation. The level of TGF-beta1 is elevated in many chronic inflammatory lung disorders associated with oxidant/antioxidant imbalance. In this study, we show that TGF-beta1 depletes GSH by down-regulating expression of the enzyme responsible for its formation, gamma-glutamylcysteine synthetase (gamma-GCS) and induces reactive oxygen species production in type II alveolar epithelial cells (A549). To investigate the molecular mechanisms of inhibition of glutathione synthesis, we employed reporters containing fragments from the promoter region of the gamma-GCS heavy subunit (h), the gene that encodes the catalytic subunit of gamma-GCS. We found that TGF-beta1 reduced the expression of the long gamma-GCSh construct (-3802/GCSh-5'-Luc), suggesting that an antioxidant response element (ARE) may be responsible for mediating the TGF-beta1 effect. Interestingly, the electrophoretic mobility shift assay revealed that the DNA binding activity of both activator protein-1 (AP-1) and ARE was increased in TGF-beta1-treated epithelial cells. The gamma-GCSh ARE contains a perfect AP-1 site embedded within it, and mutation of this internal AP-1 sequence, but not the surrounding ARE, prevented DNA binding. Further studies revealed that c-Jun and Fra-1 dimers, members of the AP-1 family previously shown to exert a negative effect on phase II gene expression, bound to the ARE sequence. We propose a novel mechanism of gamma-GCSh down-regulation by TGF-beta1 that involves the binding of c-Jun and Fra-1 dimers to the distal promoter. The findings of this study provide important information, which may be used for the modulation of glutathione biosynthesis in inflammation.
AuthorsHazel Jardine, William MacNee, Kenneth Donaldson, Irfan Rahman
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 277 Issue 24 Pg. 21158-66 (Jun 14 2002) ISSN: 0021-9258 [Print] United States
PMID11912197 (Publication Type: Journal Article)
Chemical References
  • Antioxidants
  • Proto-Oncogene Proteins c-fos
  • RNA, Messenger
  • Reactive Oxygen Species
  • TGFB1 protein, human
  • Transcription Factor AP-1
  • Transforming Growth Factor beta
  • Transforming Growth Factor beta1
  • fos-related antigen 1
  • DNA
  • Chloramphenicol O-Acetyltransferase
  • Glutamate-Cysteine Ligase
  • Glutathione
Topics
  • Antioxidants (metabolism)
  • Cell Differentiation
  • Cell Division
  • Cell Line
  • Chloramphenicol O-Acetyltransferase (metabolism)
  • DNA (metabolism)
  • DNA Mutational Analysis
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Epithelial Cells (metabolism)
  • Genes, Reporter
  • Glutamate-Cysteine Ligase (metabolism)
  • Glutathione (metabolism)
  • Humans
  • Models, Biological
  • Protein Binding
  • Protein Structure, Tertiary
  • Proto-Oncogene Proteins c-fos (metabolism)
  • Pulmonary Alveoli (metabolism)
  • RNA, Messenger (metabolism)
  • Reactive Oxygen Species
  • Response Elements
  • Time Factors
  • Transcription Factor AP-1 (metabolism)
  • Transfection
  • Transforming Growth Factor beta (metabolism)
  • Transforming Growth Factor beta1

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: